Abdominal wall endometriosis – clinical pattern and treatment

In: Obstetrica şi Ginecologia · 2019 · vol. 4(67) , pp. 163 · doi:10.26416/obsgin.67.4.2019.2760 · W3002977238
article OA: hybrid CC0
AI-generated summary by claude@2026-06, 2026-06-08

Abdominal wall endometriosis, often presenting as painful, menstrually-linked masses in surgical scars, is best treated surgically despite hormonal therapies having limited long-term success.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is a benign inflammatory disease that affects a large proportion of women in their reproductive age. A peculiar type is the one situated on the postsurgical scars in the form of endometriomas. Whilst most patients with this pathology do not have a history of pelvic endometriosis, the explanation for its appearance is the theory of implantation of endometriotic cells during surgery, as well as the existence of primitive, pluripotent mesenchymal cells that have undergone differentiation and metaplasia processes. Pain is the main symptom of this condition, accompanied frequently by the appearance of an abdominal wall mass, which are both influenced by menstrual periods. Endometriosis is an estrogen dependent disease, thus the medical treatment could comprise contraceptives containing progesterone, as well as antiestrogens, but the long-term success rate is low, the treatment of choice being the surgical one.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (28)

Source provenance

openalex
last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0 · commercial use OK